The Eclipse Corporate Finance team is delighted to have been named as a finalist in the "Financial Advisor of the Year" category of the LaingBuisson Awards 2024.
The LaingBuisson Awards honour businesses that establish new benchmarks of excellence in their respective industries. Now in their 19th year of recognising outstanding achievements, these awards are assessed independently and objectively, focusing on both the individuals delivering care and their advisors.
Eclipse has been recognised after successfully advising on a range of deals across the healthcare sector, including:
the sale of Enable Therapy Services to Examworks UK;
the sale of HealthHarmonie to Medinet (backed by Fremman Capital);
the sale of Remedy Healthcare Solutions to Medinet (backed by Fremman Capital);
the sale of Lucis Pharma to Rosemont Pharmaceuticals (backed by Inflexion Capital);
the sale of Fox Covert Limited to Aurem Care (a partnership between Salutem Care & Education and Gresham House Plc).
With a number of interesting transactions ongoing and a strong pipeline of future opportunities, we are pleased that the successes of our team have been recognised by being shortlisted for this prestigious award.
Congratulations to all of the finalists and we will look forward to celebrating the successes of the sector on 21st November.
Comments